ETF SER SOLUTIONS - RANGE CANCER THE (CNCR)

Historical Portfolio Holders from Q4 2015 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / RANGE CANCER THE
Shares, excl. options Q2 2024
104K
Holdings value Q2 2024
$1.4M
Value change Q2 2024
-$652K
Grand Portfolio weight change Q2 2024
0%
Number of holders
13
Number of buys Q2 2024
0
Number of sells Q2 2024
-1
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 873 $13.1K -$7.28K $14.96 2
2024 Q2 104K $1.4M -$652K $13.51 13
2024 Q1 138K $2.29M +$315K $16.62 16
2023 Q4 127K $1.7M -$240K $13.47 13
2023 Q3 144K $1.57M -$250K $10.96 15
2023 Q2 167K $2.15M -$6.42M $12.92 14
2023 Q1 704K $8.44M -$146K $11.99 14
2022 Q4 716K $9.84M +$2.21M $13.73 19
2022 Q3 557K $8.17M -$2.44M $14.65 17
2022 Q2 723K $11M +$1.58M $15.19 16
2022 Q1 613K $11M +$3.57M $18.00 17
2021 Q4 401K $9.54M -$2.4M $23.80 20
2021 Q3 488K $14.8M -$2.19M $30.36 20
2021 Q2 574K $18.3M +$1.12M $31.88 19
2021 Q1 539K $16.1M +$1M $29.93 20
2020 Q4 507K $16.1M -$1.26M $31.72 22
2020 Q3 552K $15.1M +$343K $27.46 21
2020 Q2 539K $14.6M +$196K $27.09 20
2020 Q1 532K $10.4M +$981K $19.54 18
2019 Q4 481K $11.3M +$667K $23.44 23
2019 Q3 457K $8.55M +$576K $18.76 21
2019 Q2 421K $8.89M +$442K $21.12 20
2019 Q1 400K $8.41M -$2.38M $21.02 20
2018 Q4 307K $5.78M -$350K $18.87 21
2018 Q3 502K $12.5M -$721K $24.83 23
2018 Q2 532K $12.8M +$1.54M $24.14 28
2018 Q1 464K $13.5M +$5.57M $29.05 22
2017 Q4 273K $6.48M -$846K $23.78 18
2017 Q3 290K $7.84M +$1.15M $27.05 13
2017 Q2 247K $5.7M +$1.06M $23.03 11
2017 Q1 201K $4.89M -$586K $24.23 8
2016 Q4 233K $4.96M +$2.34M $21.10 12
2016 Q3 112K $2.89M +$69.9K $25.79 10
2016 Q2 110K $2.52M -$165K $22.70 11
2016 Q1 115K $2.58M -$279K $21.71 11
2015 Q4 111K $3.12M +$3.12M $28.57 11